Oulai Ning (欧来宁)欧来宁
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 石药集团欧意药业有限公司Chinese legal name: 石药集团欧意药业有限公司
主要成分Active Ingredients
- 奥拉西坦Aola Xitan
药物知识说明
奥拉西坦是一种在国家药监局注册认定的药品。标注生产企业为石药集团欧意药业有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：石药集团欧意药业有限公司Chinese legal name: 石药集团欧意药业有限公司、石药集团欧意药业有限公司Chinese legal name: 石药集团欧意药业有限公司、石药集团欧意药业有限公司Chinese legal name: 石药集团欧意药业有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 欧来宁) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 石药集团欧意药业有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 石药集团欧意药业有限公司Chinese legal name: 石药集团欧意药业有限公司, 石药集团欧意药业有限公司Chinese legal name: 石药集团欧意药业有限公司, 石药集团欧意药业有限公司Chinese legal name: 石药集团欧意药业有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 欧来宁Recorded Chinese name: 欧来宁
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 0.4g*24粒0.4 g × 24 capsules
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 石药集团欧意药业有限公司Chinese legal name: 石药集团欧意药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20031033
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20031033
Manufacturer
Chinese legal name: 石药集团欧意药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Keep sealed.
Specification
0.4 g × 24 capsules
中文说明书原文Original Chinese source label
批准文号
国药准字H20031033
生产企业
石药集团欧意药业有限公司(国产)
适应症
本品适用于轻中度血管性痴呆、老年性痴呆以及脑外伤等症引起的记忆与智能障碍。
用法用量
口服，每次2粒(800mg)，每日2～3次，或遵医嘱。
不良反应
据国外文献报道，奥拉西坦的不良反应少见，少数患者出现精神兴奋和睡眠异常。本品在3 5 7例Ⅱ期临床研究中，仅个别患者出现恶心和胃部不适。
禁忌
对本品过敏者禁用。
注意事项
1、肾功能不全者应慎用必乡页使用表品时．应降低剂量。
2、患者出现精神兴奋和睡眠异常表现时，应减量。
贮藏
密封。
规格
0.4g*24粒
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.